Kras Codon 61 Mutation Detection, Tissue
Overview of Kras Codon 61 Mutation Detection, Tissue in Kozhikode
What is the KRAS Codon 61 Mutation Detection Test?
The KRAS Codon 61 Mutation Detection Test identifies mutations in codon 61 of the KRAS gene, which may indicate resistance to certain cancer therapies, especially in colorectal and lung cancers.
Who should get this test?
This test is recommended for:
Patients with colorectal cancer or non-small cell lung cancer (NSCLC).
Individuals being considered for targeted therapies such as EGFR inhibitors.
Cancer patients who require mutation profiling for treatment planning.
How is the test performed?
A tissue sample or liquid biopsy is analyzed using PCR or next-generation sequencing (NGS) to detect codon 61 mutations in the KRAS gene.
What do the results indicate?
Mutant Result: Presence of a mutation, indicating potential resistance to EGFR-targeted therapies.
Wild-Type Result: No mutation, suggesting possible eligibility for targeted therapies.
Why is this test important?
Detecting KRAS mutations guides personalized treatment strategies, ensuring appropriate therapeutic interventions.
Test included
- Preliminary Report
- Kras Codon 61 Mutation
- Block Identification Number
- Clinical Details
Doctor information
Test code
RD1315
CPT and Loinc codes
Department
- Advanced Molecular Diagnostics R&d
Turn around time
7 Working Days
Test run frequency
Every Day TIME - 09:30
Performing locations
1 labs across India
Specimen vol. and vacutainer information
| Specimen | Vacutainer | Volume |
|---|---|---|
| Tissue | Others | 1 NOS |
Specimen stability information
Tissue
Collection instructions
Site Of Biopsy & Clinical Details Mandatory If Tissue Recd.
Test price
₹5500
Need Help?
Talk to our health experts for guidance on tests, reports, or bookings.
WhatsApp to Book TestKras Codon 61 Mutation Detection, Tissue
₹5500